While dual targeting of CCR5 and CXCR4 co-receptors appears promising for control of HIV-1 infection, there are concerns that ablating the CXCR4 receptor in certain cell types will lead to detrimental effects. This evidence concerns the gene CCR5 and HIV-1 infection.